News
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Aurora Cannabis posted mixed Q1 FY2026 results, facing sales pressure, covenant issues, and looming German regulatory risks.
Stocktwits on MSN3d
Retail Bulls Pile Into Cannabis Stocks On Reports Trump May Reclassify Marijuana; Traders Eye Aurora Rally
Canopy Growth (CGC), Cronos Group (CRON) and Trulieve Cannabis (TCNNF) after reports that U.S. President Donald Trump may ...
If you invested in Canadian cannabis stocks just after legalization in 2018, at the height of investor fervor, you are likely ...
Shares of major cannabis companies are trading higher Monday morning. The stocks are soaring following a WSJ report that ...
To say Aurora Cannabis (NASDAQ: ACB) has faced some challenges over the years would be a huge understatement. The once-leading cannabis producer in the Canadian marijuana industry is now a shell ...
U.S. President Donald Trump’s administration is looking to reclassify marijuana as a less dangerous drug, a shift that could ...
Even a skeptic will be forced to admit that Aurora Cannabis seems to be experiencing mounting momentum. The cannabis company's net revenue jumped 30% year over year, to 63.4 million in Canadian ...
Should you buy Aurora Cannabis' stock today? Although Aurora is getting closer to adjusted EBITDA profitability, its net loss was still CA$51.9 million in Q1.
The Aurora City Council on Monday night gave preliminary approval, by an 8-2 vote, to cannabis delivery in Colorado’s third-largest city.
Potency Cultivars, Expanding Patient Choice in Australia EDMONTON, ALBERTA, Aug. 12, 2025 /CNW/ – Aurora Cannabis Inc. (NASDAQ: ACB) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback